Glucose Health (Glucose Health) FCF Margin % : 0.00% (As of Sep. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Glucose Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Glucose Health's Free Cash Flow for the three months ended in Sep. 2023 was $0.00 Mil. Glucose Health's Revenue for the three months ended in Sep. 2023 was $0.12 Mil. Therefore, Glucose Health's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, Glucose Health's current FCF Yield % is -0.67%.

The historical rank and industry rank for Glucose Health's FCF Margin % or its related term are showing as below:

GLUC' s FCF Margin % Range Over the Past 10 Years
Min: -5500 Med: -471.15 Max: -12.46
Current: -33.91

During the past 10 years, the highest FCF Margin % of Glucose Health was -12.46%. The lowest was -5500.00%. And the median was -471.15%.

GLUC's FCF Margin % is ranked worse than
91.26% of 1877 companies
in the Consumer Packaged Goods industry
Industry Median: 2.23 vs GLUC: -33.91

Glucose Health FCF Margin % Historical Data

The historical data trend for Glucose Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glucose Health FCF Margin % Chart

Glucose Health Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

FCF Margin %

Get a 7-Day Free Trial

-4,500.00

-2,900.00

-12.46

Glucose Health Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Mar18	Jun18	Sep22	Sep23
FCF Margin %	Get a 7-Day Free Trial															-8.33	-123.68	72.46	-	-

Competitive Comparison of Glucose Health's FCF Margin %

For the Packaged Foods subindustry, Glucose Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Glucose Health's FCF Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Glucose Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Glucose Health's FCF Margin % falls into.

Glucose Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Glucose Health's FCF Margin for the fiscal year that ended in Dec. 2016 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2016 )	/	Revenue (A: Dec. 2016 )
	=	-0.039	/	0.313
	=	-12.46 %

Glucose Health's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0	/	0.115
	=	0.00 %

Glucose Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Glucose Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Glucose Health (Glucose Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Glucose Health Inc (OTCPK:GLUC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

609 SW 8th Street, Suite 600, 6th Floor, Bentonville, AR, USA, 72712

Website

https://www.glucosehealthinc.com

Glucose Health Inc is a manufacturer of dietary supplements formulated to help maintain healthy blood sugar, triglycerides and cholesterol and digestive health. The company's focus is serving the consumer market segment of persons concerned about pre-diabetes and/or Type-2 diabetes. The firm sells its product through national and regional pharmacy retailers.

Executives

Murray Fleming

10 percent owner, officer: CEO, CFO

609 SW 8TH STREET, SUITE 600, BENTONVILLE AR 72712